Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge

Abstract Introduction Recognition of psychiatric manifestations of Wilson's disease (WD) has diagnostic and therapeutic implications. Objective To describe the clinical features and psychopathology of patients with WD who had initial or predominant psychiatric manifestations. Patient and method...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the neurological sciences 2008-03, Vol.266 (1), p.104-108
Hauptverfasser: Srinivas, K, Sinha, S, Taly, A.B, Prashanth, L.K, Arunodaya, G.R, Janardhana Reddy, Y.C, Khanna, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 108
container_issue 1
container_start_page 104
container_title Journal of the neurological sciences
container_volume 266
creator Srinivas, K
Sinha, S
Taly, A.B
Prashanth, L.K
Arunodaya, G.R
Janardhana Reddy, Y.C
Khanna, S
description Abstract Introduction Recognition of psychiatric manifestations of Wilson's disease (WD) has diagnostic and therapeutic implications. Objective To describe the clinical features and psychopathology of patients with WD who had initial or predominant psychiatric manifestations. Patient and methods Records of 15 patients with WD (M:F: 11:4), from a large cohort of 350 patients, with predominant psychiatric manifestations at onset were reviewed. Their initial diagnosis, demographic profile, family history, pre-morbid personality, clinical manifestations, treatment and outcome were recorded. Results Their mean age at diagnosis was 19.8 ± 5.8 years. Six patients were born to consanguineous parentage and two patients each had family history of WD and past history of psychiatric illness. Diagnosis of WD was suspected by detection of KF rings (all), observing sensitivity to neuroleptics ( n = 2), history of jaundice ( n = 2) and family history suggestive of WD ( n = 9). Psychiatric manifestations could be classified as affective disorder spectrum ( n = 11) and schizophreniform-illness ( n = 3). While the psychiatric symptoms improved in five patients with de-coppering therapy, seven patients needed symptomatic treatment as well. Three of the four patients who responded to de-coppering therapy were sensitive to neuroleptics. Long-term follow up of 10 patients revealed variable recovery. Conclusions Young patient with psychiatric manifestations with clues like history of jaundice, family history of neuropsychiatric manifestations and sensitivity to neuroleptics should be evaluated for WD to avoid delay in diagnosis and associated morbidity. Significant outcomes The study reemphasizes the importance of behavioral manifestations in Wilson disease in terms of diagnosis and management difficulties. Limitations Retrospective nature of the study.
doi_str_mv 10.1016/j.jns.2007.09.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70278682</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022510X07006363</els_id><sourcerecordid>70278682</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-4b10590e5510b17e6c3df69add6b6eea56dd7e72a6f79e7a36709c98eef1e1ab3</originalsourceid><addsrcrecordid>eNp9kU2L1TAUhoMozp3RH-BGulFXrSftNB8KwjDjFwy4UNFdSJPTuam96TWnFe6_N-VeFFy4SgLPe_LyHMaecKg4cPFyqIZIVQ0gK9AVgL7HNlxJVbZKNffZBqCuy5bD9zN2TjQAgFBKP2RnXGq45AI2zNxMuxBtnIs9Hdw22DkFV-xsDD3SbOcwRSpCLL6Fkab4ggofCC3hq-IqX-1dnGjOARt9MW8x2T0u69tt7ThivMNH7EFvR8LHp_OCfX339sv1h_L20_uP11e3pWuhnsvLjkOrAdvctuMShWt8L7T1XnQC0bbCe4mytqKXGqVthATttELsOXLbNRfs-XHuPk0_l1zd7AI5HEcbcVrISKilEqrOID-CLk1ECXuzT2Fn08FwMKtVM5hs1axWDWiTrebM09Pwpduh_5s4aczAsxNgydmxTza6QH-4PEtxyUXmXh85zCp-BUyGXMDo0IeEbjZ-Cv-t8eaftBtDDPnDH3hAGqYlxezYcEO1AfN5Xf-6fZB58Y1omt81RKuR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70278682</pqid></control><display><type>article</type><title>Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Srinivas, K ; Sinha, S ; Taly, A.B ; Prashanth, L.K ; Arunodaya, G.R ; Janardhana Reddy, Y.C ; Khanna, S</creator><creatorcontrib>Srinivas, K ; Sinha, S ; Taly, A.B ; Prashanth, L.K ; Arunodaya, G.R ; Janardhana Reddy, Y.C ; Khanna, S</creatorcontrib><description>Abstract Introduction Recognition of psychiatric manifestations of Wilson's disease (WD) has diagnostic and therapeutic implications. Objective To describe the clinical features and psychopathology of patients with WD who had initial or predominant psychiatric manifestations. Patient and methods Records of 15 patients with WD (M:F: 11:4), from a large cohort of 350 patients, with predominant psychiatric manifestations at onset were reviewed. Their initial diagnosis, demographic profile, family history, pre-morbid personality, clinical manifestations, treatment and outcome were recorded. Results Their mean age at diagnosis was 19.8 ± 5.8 years. Six patients were born to consanguineous parentage and two patients each had family history of WD and past history of psychiatric illness. Diagnosis of WD was suspected by detection of KF rings (all), observing sensitivity to neuroleptics ( n = 2), history of jaundice ( n = 2) and family history suggestive of WD ( n = 9). Psychiatric manifestations could be classified as affective disorder spectrum ( n = 11) and schizophreniform-illness ( n = 3). While the psychiatric symptoms improved in five patients with de-coppering therapy, seven patients needed symptomatic treatment as well. Three of the four patients who responded to de-coppering therapy were sensitive to neuroleptics. Long-term follow up of 10 patients revealed variable recovery. Conclusions Young patient with psychiatric manifestations with clues like history of jaundice, family history of neuropsychiatric manifestations and sensitivity to neuroleptics should be evaluated for WD to avoid delay in diagnosis and associated morbidity. Significant outcomes The study reemphasizes the importance of behavioral manifestations in Wilson disease in terms of diagnosis and management difficulties. Limitations Retrospective nature of the study.</description><identifier>ISSN: 0022-510X</identifier><identifier>EISSN: 1878-5883</identifier><identifier>DOI: 10.1016/j.jns.2007.09.009</identifier><identifier>PMID: 17904160</identifier><identifier>CODEN: JNSCAG</identifier><language>eng</language><publisher>Shannon: Elsevier B.V</publisher><subject>Adolescent ; Adult ; Behavioral changes ; Biological and medical sciences ; Chelating Agents - therapeutic use ; Cohort Studies ; Copper - antagonists &amp; inhibitors ; Copper - blood ; Copper - urine ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Depressive Disorder - etiology ; Depressive Disorder - psychology ; Female ; Follow-Up Studies ; Hepatolenticular Degeneration - diagnosis ; Hepatolenticular Degeneration - psychology ; Hepatolenticular Degeneration - therapy ; Humans ; Longitudinal Studies ; Male ; Medical sciences ; Mental Disorders - etiology ; Mental Disorders - psychology ; Mood Disorders - etiology ; Mood Disorders - psychology ; Neurology ; Penicillamine - therapeutic use ; Psychiatric symptoms ; Psychosis ; Psychotic Disorders - etiology ; Psychotic Disorders - psychology ; Schizophrenia - etiology ; Wilson's disease ; Zinc Sulfate - therapeutic use</subject><ispartof>Journal of the neurological sciences, 2008-03, Vol.266 (1), p.104-108</ispartof><rights>Elsevier B.V.</rights><rights>2007 Elsevier B.V.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-4b10590e5510b17e6c3df69add6b6eea56dd7e72a6f79e7a36709c98eef1e1ab3</citedby><cites>FETCH-LOGICAL-c502t-4b10590e5510b17e6c3df69add6b6eea56dd7e72a6f79e7a36709c98eef1e1ab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022510X07006363$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20081716$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17904160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Srinivas, K</creatorcontrib><creatorcontrib>Sinha, S</creatorcontrib><creatorcontrib>Taly, A.B</creatorcontrib><creatorcontrib>Prashanth, L.K</creatorcontrib><creatorcontrib>Arunodaya, G.R</creatorcontrib><creatorcontrib>Janardhana Reddy, Y.C</creatorcontrib><creatorcontrib>Khanna, S</creatorcontrib><title>Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge</title><title>Journal of the neurological sciences</title><addtitle>J Neurol Sci</addtitle><description>Abstract Introduction Recognition of psychiatric manifestations of Wilson's disease (WD) has diagnostic and therapeutic implications. Objective To describe the clinical features and psychopathology of patients with WD who had initial or predominant psychiatric manifestations. Patient and methods Records of 15 patients with WD (M:F: 11:4), from a large cohort of 350 patients, with predominant psychiatric manifestations at onset were reviewed. Their initial diagnosis, demographic profile, family history, pre-morbid personality, clinical manifestations, treatment and outcome were recorded. Results Their mean age at diagnosis was 19.8 ± 5.8 years. Six patients were born to consanguineous parentage and two patients each had family history of WD and past history of psychiatric illness. Diagnosis of WD was suspected by detection of KF rings (all), observing sensitivity to neuroleptics ( n = 2), history of jaundice ( n = 2) and family history suggestive of WD ( n = 9). Psychiatric manifestations could be classified as affective disorder spectrum ( n = 11) and schizophreniform-illness ( n = 3). While the psychiatric symptoms improved in five patients with de-coppering therapy, seven patients needed symptomatic treatment as well. Three of the four patients who responded to de-coppering therapy were sensitive to neuroleptics. Long-term follow up of 10 patients revealed variable recovery. Conclusions Young patient with psychiatric manifestations with clues like history of jaundice, family history of neuropsychiatric manifestations and sensitivity to neuroleptics should be evaluated for WD to avoid delay in diagnosis and associated morbidity. Significant outcomes The study reemphasizes the importance of behavioral manifestations in Wilson disease in terms of diagnosis and management difficulties. Limitations Retrospective nature of the study.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Behavioral changes</subject><subject>Biological and medical sciences</subject><subject>Chelating Agents - therapeutic use</subject><subject>Cohort Studies</subject><subject>Copper - antagonists &amp; inhibitors</subject><subject>Copper - blood</subject><subject>Copper - urine</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Depressive Disorder - etiology</subject><subject>Depressive Disorder - psychology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hepatolenticular Degeneration - diagnosis</subject><subject>Hepatolenticular Degeneration - psychology</subject><subject>Hepatolenticular Degeneration - therapy</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mental Disorders - etiology</subject><subject>Mental Disorders - psychology</subject><subject>Mood Disorders - etiology</subject><subject>Mood Disorders - psychology</subject><subject>Neurology</subject><subject>Penicillamine - therapeutic use</subject><subject>Psychiatric symptoms</subject><subject>Psychosis</subject><subject>Psychotic Disorders - etiology</subject><subject>Psychotic Disorders - psychology</subject><subject>Schizophrenia - etiology</subject><subject>Wilson's disease</subject><subject>Zinc Sulfate - therapeutic use</subject><issn>0022-510X</issn><issn>1878-5883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2L1TAUhoMozp3RH-BGulFXrSftNB8KwjDjFwy4UNFdSJPTuam96TWnFe6_N-VeFFy4SgLPe_LyHMaecKg4cPFyqIZIVQ0gK9AVgL7HNlxJVbZKNffZBqCuy5bD9zN2TjQAgFBKP2RnXGq45AI2zNxMuxBtnIs9Hdw22DkFV-xsDD3SbOcwRSpCLL6Fkab4ggofCC3hq-IqX-1dnGjOARt9MW8x2T0u69tt7ThivMNH7EFvR8LHp_OCfX339sv1h_L20_uP11e3pWuhnsvLjkOrAdvctuMShWt8L7T1XnQC0bbCe4mytqKXGqVthATttELsOXLbNRfs-XHuPk0_l1zd7AI5HEcbcVrISKilEqrOID-CLk1ECXuzT2Fn08FwMKtVM5hs1axWDWiTrebM09Pwpduh_5s4aczAsxNgydmxTza6QH-4PEtxyUXmXh85zCp-BUyGXMDo0IeEbjZ-Cv-t8eaftBtDDPnDH3hAGqYlxezYcEO1AfN5Xf-6fZB58Y1omt81RKuR</recordid><startdate>20080315</startdate><enddate>20080315</enddate><creator>Srinivas, K</creator><creator>Sinha, S</creator><creator>Taly, A.B</creator><creator>Prashanth, L.K</creator><creator>Arunodaya, G.R</creator><creator>Janardhana Reddy, Y.C</creator><creator>Khanna, S</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080315</creationdate><title>Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge</title><author>Srinivas, K ; Sinha, S ; Taly, A.B ; Prashanth, L.K ; Arunodaya, G.R ; Janardhana Reddy, Y.C ; Khanna, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-4b10590e5510b17e6c3df69add6b6eea56dd7e72a6f79e7a36709c98eef1e1ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Behavioral changes</topic><topic>Biological and medical sciences</topic><topic>Chelating Agents - therapeutic use</topic><topic>Cohort Studies</topic><topic>Copper - antagonists &amp; inhibitors</topic><topic>Copper - blood</topic><topic>Copper - urine</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Depressive Disorder - etiology</topic><topic>Depressive Disorder - psychology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hepatolenticular Degeneration - diagnosis</topic><topic>Hepatolenticular Degeneration - psychology</topic><topic>Hepatolenticular Degeneration - therapy</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mental Disorders - etiology</topic><topic>Mental Disorders - psychology</topic><topic>Mood Disorders - etiology</topic><topic>Mood Disorders - psychology</topic><topic>Neurology</topic><topic>Penicillamine - therapeutic use</topic><topic>Psychiatric symptoms</topic><topic>Psychosis</topic><topic>Psychotic Disorders - etiology</topic><topic>Psychotic Disorders - psychology</topic><topic>Schizophrenia - etiology</topic><topic>Wilson's disease</topic><topic>Zinc Sulfate - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Srinivas, K</creatorcontrib><creatorcontrib>Sinha, S</creatorcontrib><creatorcontrib>Taly, A.B</creatorcontrib><creatorcontrib>Prashanth, L.K</creatorcontrib><creatorcontrib>Arunodaya, G.R</creatorcontrib><creatorcontrib>Janardhana Reddy, Y.C</creatorcontrib><creatorcontrib>Khanna, S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Srinivas, K</au><au>Sinha, S</au><au>Taly, A.B</au><au>Prashanth, L.K</au><au>Arunodaya, G.R</au><au>Janardhana Reddy, Y.C</au><au>Khanna, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge</atitle><jtitle>Journal of the neurological sciences</jtitle><addtitle>J Neurol Sci</addtitle><date>2008-03-15</date><risdate>2008</risdate><volume>266</volume><issue>1</issue><spage>104</spage><epage>108</epage><pages>104-108</pages><issn>0022-510X</issn><eissn>1878-5883</eissn><coden>JNSCAG</coden><abstract>Abstract Introduction Recognition of psychiatric manifestations of Wilson's disease (WD) has diagnostic and therapeutic implications. Objective To describe the clinical features and psychopathology of patients with WD who had initial or predominant psychiatric manifestations. Patient and methods Records of 15 patients with WD (M:F: 11:4), from a large cohort of 350 patients, with predominant psychiatric manifestations at onset were reviewed. Their initial diagnosis, demographic profile, family history, pre-morbid personality, clinical manifestations, treatment and outcome were recorded. Results Their mean age at diagnosis was 19.8 ± 5.8 years. Six patients were born to consanguineous parentage and two patients each had family history of WD and past history of psychiatric illness. Diagnosis of WD was suspected by detection of KF rings (all), observing sensitivity to neuroleptics ( n = 2), history of jaundice ( n = 2) and family history suggestive of WD ( n = 9). Psychiatric manifestations could be classified as affective disorder spectrum ( n = 11) and schizophreniform-illness ( n = 3). While the psychiatric symptoms improved in five patients with de-coppering therapy, seven patients needed symptomatic treatment as well. Three of the four patients who responded to de-coppering therapy were sensitive to neuroleptics. Long-term follow up of 10 patients revealed variable recovery. Conclusions Young patient with psychiatric manifestations with clues like history of jaundice, family history of neuropsychiatric manifestations and sensitivity to neuroleptics should be evaluated for WD to avoid delay in diagnosis and associated morbidity. Significant outcomes The study reemphasizes the importance of behavioral manifestations in Wilson disease in terms of diagnosis and management difficulties. Limitations Retrospective nature of the study.</abstract><cop>Shannon</cop><pub>Elsevier B.V</pub><pmid>17904160</pmid><doi>10.1016/j.jns.2007.09.009</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-510X
ispartof Journal of the neurological sciences, 2008-03, Vol.266 (1), p.104-108
issn 0022-510X
1878-5883
language eng
recordid cdi_proquest_miscellaneous_70278682
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adolescent
Adult
Behavioral changes
Biological and medical sciences
Chelating Agents - therapeutic use
Cohort Studies
Copper - antagonists & inhibitors
Copper - blood
Copper - urine
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Depressive Disorder - etiology
Depressive Disorder - psychology
Female
Follow-Up Studies
Hepatolenticular Degeneration - diagnosis
Hepatolenticular Degeneration - psychology
Hepatolenticular Degeneration - therapy
Humans
Longitudinal Studies
Male
Medical sciences
Mental Disorders - etiology
Mental Disorders - psychology
Mood Disorders - etiology
Mood Disorders - psychology
Neurology
Penicillamine - therapeutic use
Psychiatric symptoms
Psychosis
Psychotic Disorders - etiology
Psychotic Disorders - psychology
Schizophrenia - etiology
Wilson's disease
Zinc Sulfate - therapeutic use
title Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T18%3A50%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dominant%20psychiatric%20manifestations%20in%20Wilson's%20disease:%20A%20diagnostic%20and%20therapeutic%20challenge&rft.jtitle=Journal%20of%20the%20neurological%20sciences&rft.au=Srinivas,%20K&rft.date=2008-03-15&rft.volume=266&rft.issue=1&rft.spage=104&rft.epage=108&rft.pages=104-108&rft.issn=0022-510X&rft.eissn=1878-5883&rft.coden=JNSCAG&rft_id=info:doi/10.1016/j.jns.2007.09.009&rft_dat=%3Cproquest_cross%3E70278682%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70278682&rft_id=info:pmid/17904160&rft_els_id=S0022510X07006363&rfr_iscdi=true